BiomX (PHGE) Price to Book (2019 - 2026)
BiomX's (PHGE) quarterly Price to Book came in at 0.2 in Q2 2026, down 67.02% year-over-year from 0.62 in Q2 2025, and up 101.85% quarter-over-quarter from 11.09 in Q1 2026.
Analysis
BiomX (PHGE) Price to Book (2019 - 2026) Analysis & Trends
BiomX has disclosed Price to Book across 8 years of filings, most recently posting 0.2 for Q2 2026.
- In Q2 2026, Price to Book fell 67.02% year-over-year to 0.2; the TTM figure through Jun 2026 stood at 0.2 (down 67.02% YoY), while the FY2025 annual figure was 2.29, down 729.89% from the prior year.
- Price to Book came in at 0.2 for Q2 2026 at BiomX, up from 11.09 in the prior quarter.
- In the past five years, Price to Book ranged from a high of 7.11 in Q4 2023 to a low of 11.09 in Q1 2026.
- Average Price to Book over 5 years is 0.54, with a median of 0.68 recorded in 2022.
- Year-over-year, Price to Book jumped 924.11% in 2023 and slumped 2059.34% in 2026.
- Over 5 years, Price to Book stood at 0.69 in 2022, then jumped by 924.11% to 7.11 in 2023, then plunged by 94.89% to 0.36 in 2024, then tumbled by 729.89% to 2.29 in 2025, then jumped by 108.95% to 0.2 in 2026.
- Per Business Quant data, the three most recent Price to Book figures were 0.2 in Q2 2026, 11.09 in Q1 2026, and 2.29 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BiomX | 1.55 Mn | 7.73 Mn | 97,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.20 |
| Mar 31, 2026 | -11.09 |
| Dec 31, 2025 | -2.29 |
| Sep 30, 2025 | 1.34 |
| Jun 30, 2025 | 0.62 |
| Mar 31, 2025 | 0.57 |
| Dec 31, 2024 | 0.36 |
| Sep 30, 2024 | 0.49 |
| Jun 30, 2024 | 0.86 |
| Mar 15, 2024 | 1.81 |
| Dec 31, 2023 | 7.11 |
| Sep 30, 2023 | 3.38 |
| Jun 30, 2023 | 1.78 |
| Mar 31, 2023 | 1.48 |
| Dec 31, 2022 | 0.69 |
| Sep 30, 2022 | 0.38 |
| Jun 30, 2022 | 0.66 |
| Mar 31, 2022 | 1.44 |
| Dec 31, 2021 | 1.00 |
| Sep 30, 2021 | 1.62 |